← Back to Analyst Consensus 
LPCN Buy
Lipocine Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 21, 2026 | HC Wainwright & Co. | reiterate | Neutral → Neutral | — | 44% |
| Apr 6, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Jan 21, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $15 | 44% |
| Nov 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Aug 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jun 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jun 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jul 27, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $33 | 50% |
Price Target Trend
Apr 2, 2026 Oct 26, 2026
EPS Estimates
0q —
+1y —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days